RxDoctor Payments Data

Paul Rothman

Rheumatology · Iowa City, IANPI 1316935273

Payments from drug & device makers

What this record shows

This record is dominated by travel and lodging: $202,292 of the $216,914 with a category attached, or 93.3%. Every reported general payment came from a single manufacturer, Merck. 2024 is the largest year on record at $65,397, 2.0 times the $32,658 reported in 2019. Among rheumatology clinicians in IA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$216,914in general payments, 2019–2025

Across 352 payments — averaging $616.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Merck$217K

What the payments were for

  • Speaking & faculty fees$180%
  • Travel & lodging$202,29293%
  • Food & beverage$14,6057%

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Merck352$216,914

How this compares

$216,914 in reported general payments places this provider in the 95th percentile of 50 rheumatology providers in Iowa.

See all rheumatology providers in Iowa →

Other rheumatology in Iowa City

See the full list for Iowa →

Where these figures come from

Is this you, or does something look wrong? →